Total Payments
$33,642
2024 Payments
$153.72
Companies
15
Transactions
56
Medicare Patients
15,171
Medicare Billing
$1.8M
Payment Breakdown by Category
Consulting$24,800 (73.7%)
Other$4,250 (12.6%)
Travel$2,901 (8.6%)
Food & Beverage$1,692 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $24,800 | 10 | 73.7% |
| Honoraria | $4,250 | 1 | 12.6% |
| Travel and Lodging | $2,901 | 7 | 8.6% |
| Food and Beverage | $1,692 | 38 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE HEALTHCARE | $14,060 | 11 | $0 (2021) |
| Bard Peripheral Vascular, Inc. | $11,765 | 13 | $0 (2020) |
| C. R. Bard, Inc. & Subsidiaries | $5,705 | 2 | $0 (2018) |
| Allergan Inc. | $989.91 | 7 | $0 (2017) |
| Davol Inc. | $466.08 | 3 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $179.65 | 8 | $0 (2024) |
| Focal Therapeutics, Inc. | $160.79 | 2 | $0 (2020) |
| Baudax Bio Inc. | $102.49 | 1 | $0 (2021) |
| LEICA MICROSYSTEMS INC. | $101.19 | 3 | $0 (2023) |
| Siemens Medical Solutions USA, Inc. | $34.35 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153.72 | 7 | Myriad Genetic Laboratories, Inc. ($153.72) |
| 2023 | $102.39 | 3 | Davol Inc. ($41.66) |
| 2021 | $2,940 | 4 | GE HEALTHCARE ($2,803) |
| 2020 | $1,918 | 7 | Bard Peripheral Vascular, Inc. ($1,358) |
| 2019 | $12,318 | 10 | GE HEALTHCARE ($10,135) |
| 2018 | $15,015 | 12 | Bard Peripheral Vascular, Inc. ($8,289) |
| 2017 | $1,195 | 13 | Allergan Inc. ($989.91) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $39.06 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Myriad Genetic Laboratories, Inc. | BRACANALYSIS CDX (Device) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: ONCOLOGY | ||||||
| 08/12/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: ONCOLOGY | ||||||
| 08/11/2023 | LEICA MICROSYSTEMS INC. | Mammotome revolve (Device) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: Devices | ||||||
| 04/28/2023 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $41.66 | General |
| Category: Surgery | ||||||
| 12/07/2021 | Siemens Medical Solutions USA, Inc. | Mammomat Revelation (Device) | Food and Beverage | In-kind items and services | $34.35 | General |
| Category: DI - X-Ray Products | ||||||
| 10/11/2021 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $3.20 | General |
| 04/21/2021 | GE HEALTHCARE | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 03/25/2021 | Baudax Bio Inc. | ANJESO (Drug) | Food and Beverage | In-kind items and services | $102.49 | General |
| Category: Pain Management | ||||||
| 10/27/2020 | Focal Therapeutics, Inc. | LOCalizer (Device) | Food and Beverage | In-kind items and services | $78.15 | General |
| Category: Diagnostics | ||||||
| 09/15/2020 | Focal Therapeutics, Inc. | Localizer (Device), Biozorb | Food and Beverage | In-kind items and services | $82.64 | General |
| Category: Breast and Skeletal Health | ||||||
| 05/29/2020 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 05/08/2020 | Davol Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 04/29/2020 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 04/29/2020 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 02/26/2020 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: BD Interventional - Peripheral Intervention | ||||||
| 11/21/2019 | BARD PERIPHERAL VASCULAR, INC. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 11/06/2019 | NeuroLogica Corporation, A Subsidiary of Samsung Electronics | — | Food and Beverage | Cash or cash equivalent | $1.68 | General |
| Category: UltraSound | ||||||
| 10/25/2019 | BARD PERIPHERAL VASCULAR, INC. | — | Food and Beverage | In-kind items and services | $35.82 | General |
| 08/20/2019 | Philips Electronics North America Corporation | EPIQ 7G (Device) | Food and Beverage | Cash or cash equivalent | $24.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 4,373 | 5,164 | $1.4M | $459,508 |
| 2022 | 24 | 3,534 | 4,435 | $1.3M | $441,595 |
| 2021 | 24 | 3,756 | 4,469 | $1.3M | $457,165 |
| 2020 | 23 | 3,508 | 4,884 | $1.1M | $415,487 |
Total Patients
15,171
Total Services
18,952
Medicare Billing
$1.8M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76641 | Complete ultrasound scan of 1 breast | Office | 2023 | 886 | 960 | $288,605 | $115,493 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 436 | 915 | $246,135 | $82,425 | 33.5% |
| 77067 | Screening mammography | Office | 2023 | 519 | 519 | $146,358 | $52,632 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 577 | 721 | $137,033 | $45,445 | 33.2% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 251 | 259 | $103,600 | $24,700 | 23.8% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Office | 2023 | 51 | 53 | $65,508 | $22,989 | 35.1% |
| 19301 | Partial removal of breast | Facility | 2023 | 29 | 32 | $44,202 | $17,254 | 39.0% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 175 | 190 | $57,000 | $13,487 | 23.7% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 503 | 503 | $57,845 | $13,284 | 23.0% |
| 76982 | Ultrasound scan of growth for measuring elasticity, first growth | Office | 2023 | 120 | 133 | $28,329 | $10,345 | 36.5% |
| 19285 | Placement of locating device in breast using ultrasound guidance, first growth | Office | 2023 | 28 | 31 | $28,923 | $9,492 | 32.8% |
| 19302 | Partial removal of breast and underarm lymph nodes | Facility | 2023 | 13 | 13 | $23,959 | $9,361 | 39.1% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 374 | 420 | $48,300 | $8,703 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $22,555 | $8,128 | 36.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 104 | 104 | $24,232 | $7,725 | 31.9% |
| 19081 | Biopsy of breast and placement of locating device using x-ray with needle, first growth | Office | 2023 | 15 | 15 | $18,510 | $6,142 | 33.2% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 87 | 87 | $9,744 | $4,829 | 49.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 20 | $7,500 | $2,553 | 34.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $6,412 | $2,258 | 35.2% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 14 | 14 | $3,850 | $1,502 | 39.0% |
| 76983 | Ultrasound scan of growth for measuring elasticity, each additional growth | Office | 2023 | 11 | 11 | $1,569 | $574.31 | 36.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 85 | 85 | $425.00 | $187.20 | 44.0% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2022 | 855 | 1,036 | $288,965 | $110,657 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 446 | 970 | $260,930 | $88,467 | 33.9% |
| 77067 | Screening mammography | Office | 2022 | 530 | 531 | $149,498 | $53,915 | 36.1% |
About Dr. Ian Grady, MD
Dr. Ian Grady, MD is a Surgery healthcare provider based in Redding, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215951371.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ian Grady, MD has received a total of $33,642 in payments from pharmaceutical and medical device companies, with $153.72 received in 2024. These payments were reported across 56 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($24,800).
As a Medicare-enrolled provider, Grady has provided services to 15,171 Medicare beneficiaries, totaling 18,952 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Location Redding, CA
- Active Since 07/26/2006
- Last Updated 01/17/2014
- Taxonomy Code 208600000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215951371
Products in Payments
- ENCOR (Device) $4,289
- ALLODERM (Device) $989.91
- MYRISK (Device) $169.64
- ANJESO (Drug) $102.49
- Localizer (Device) $82.64
- LOCalizer (Device) $78.15
- MAMMOTOME (Device) $66.39
- Phasix Mesh (Device) $41.66
- Mammotome revolve (Device) $34.80
- Mammomat Revelation (Device) $34.35
- BPV-EnCor Enspire (Device) $27.36
- DAV-Phasix (Device) $24.42
- EPIQ 7G (Device) $24.20
- Intact (Device) $23.31
- AEROFORM TISSUE EXPANDER SYSTEM (Device) $19.13
- SPY Technology (Device) $10.21
- BRACANALYSIS CDX (Device) $10.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Redding
Paul Beck, M.d, M.D
Surgery — Payments: $69,774
Surgery $69,774
Dr. George Angelos, M.d, M.D
Surgery — Payments: $21,216
Surgery $21,216
David Penner, M.d, M.D
Surgery — Payments: $19,424
Surgery $19,424
Kent Brusett, M.d, M.D
Surgery — Payments: $17,055
Surgery $17,055
Arjun Chandrasekaran, M.d, M.D
Surgery — Payments: $5,635
Surgery $5,635
Riaz Malik, M.d, M.D
Surgery — Payments: $1,929
Surgery $1,929